Brief: Biora Therapeutics Announces Improved Bioavailability Results For Its Systemic Delivery Platform
16/02/2023 14:12
Feb 16 (Reuters) - Biora Therapeutics Inc BIOR.O :
* BIORA THERAPEUTICS ANNOUNCES IMPROVED BIOAVAILABILITY
RESULTS
FOR ITS SYSTEMIC DELIVERY PLATFORM
* BIORA THERAPEUTICS INC - AVERAGE BIOAVAILABILITY GREATER
THAN
50% FOR A VARIANT OF ADALIMUMAB
Source text for Eikon: ID:nGNX4VcSF1
Further company coverage: BIOR.O
((Reuters.briefs@thomsonreuters.com;))
Recent news on Biora Therapeutics
See all newsBiora Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Biora Therapeutics Provides Corporate Update And Reports Third Quarter 2024 Financial Results
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Brief: Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules